| Rapid onset of inflammatory bowel disease after receiving secukinumab infusion J Wang, A Bhatia, NK Cleveland, N Gupta, S Dalal, DT Rubin, A Sakuraba ACG case reports journal 5 (1), e56, 2018 | 74 | 2018 |
| What does disease progression look like in ulcerative colitis, and how might it be prevented? NK Cleveland, J Torres, DT Rubin Gastroenterology 162 (5), 1396-1408, 2022 | 72 | 2022 |
| Patients with ulcerative colitis and primary sclerosing cholangitis frequently have subclinical inflammation in the proximal colon NK Cleveland, DT Rubin, J Hart, CR Weber, K Meckel, AL Tran, ... Clinical Gastroenterology and Hepatology 16 (1), 68-74, 2018 | 62 | 2018 |
| Ustekinumab is effective for the treatment of chronic antibiotic-refractory pouchitis JE Ollech, DT Rubin, L Glick, R Weisshof, K El Jurdi, A Israel, ... Digestive diseases and sciences 64, 3596-3601, 2019 | 58 | 2019 |
| Using a treat-to-target management strategy to improve the doctor–patient relationship in inflammatory bowel disease DT Rubin, NK Cleveland Official journal of the American College of Gastroenterology| ACG 110 (9 …, 2015 | 36 | 2015 |
| Many inflammatory bowel disease patients are not immune to measles or pertussis NK Cleveland, D Rodriquez, A Wichman, I Pan, GY Melmed, DT Rubin Digestive diseases and sciences 61, 2972-2976, 2016 | 30 | 2016 |
| Surveillance of IBD using high definition colonoscopes does not miss adenocarcinoma in patients with low-grade dysplasia N Krugliak Cleveland, RJ Colman, D Rodriquez, A Hirsch, RD Cohen, ... Inflammatory bowel diseases 22 (3), 631-637, 2016 | 30 | 2016 |
| Real-world effectiveness and safety of ustekinumab for ulcerative colitis from 2 tertiary IBD centers in the United States SJ Hong, N Krugliak Cleveland, S Akiyama, S Zullow, Y Yi, SR Shaffer, ... Crohn's & Colitis 360 3 (1), otab002, 2021 | 26 | 2021 |
| Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease NK Cleveland, D Huo, F Sadiq, MA Sofia, J Marks, RD Cohen, ... Gastrointestinal endoscopy 87 (5), 1304-1309, 2018 | 25 | 2018 |
| Upadacitinib is effective and safe in both ulcerative colitis and Crohn’s disease: prospective real-world experience S Friedberg, D Choi, T Hunold, NK Choi, NM Garcia, EA Picker, ... Clinical Gastroenterology and Hepatology 21 (7), 1913-1923. e2, 2023 | 23 | 2023 |
| Combining cyclosporine with ustekinumab in acute severe ulcerative colitis SR Shaffer, C Traboulsi, NK Cleveland, DT Rubin ACG Case Reports Journal 8 (5), e00604, 2021 | 20 | 2021 |
| Penetrating disease, narcotic use, and loop ostomy are associated with ostomy and IBD-related complications after ostomy surgery in Crohn’s disease patients A Hirsch, AJ Yarur, H Dezheng, D Rodriquez, NK Cleveland, T Ali, ... Journal of gastrointestinal surgery 19 (10), 1852-1861, 2015 | 17 | 2015 |
| The role of biosimilars in inflammatory bowel disease S Paramsothy, NK Cleveland, N Zmeter, DT Rubin Gastroenterology & Hepatology 12 (12), 741, 2016 | 16 | 2016 |
| Ulcerative Colitis Patients Have Reduced Rectal Compliance Compared With Non–Inflammatory Bowel Disease Controls NK Cleveland, V Rai, K El Jurdi, SS Rao, MC Giurcanu, DT Rubin Gastroenterology 162 (1), 331-333. e1, 2022 | 15 | 2022 |
| Use of tofacitinib for the treatment of arthritis associated with ulcerative colitis W Wang, NK Cleveland, J Ollech, DT Rubin ACG Case Reports Journal 6 (9), e00226, 2019 | 14 | 2019 |
| Safety and efficacy of live measles vaccine administered to a Crohn's disease patient receiving vedolizumab A Wichmann, NK Cleveland, DT Rubin Official journal of the American College of Gastroenterology| ACG 111 (4), 577, 2016 | 14 | 2016 |
| Achieving histologic normalization in ulcerative colitis is associated with a reduced risk of subsequent dysplasia SR Shaffer, AI Erondu, C Traboulsi, V Rai, N Krugliak Cleveland, A Israel, ... Inflammatory Bowel Diseases 28 (4), 553-559, 2022 | 13 | 2022 |
| Efficacy and Follow-up of Sub-Total Colectomy With Ileo-Rectal Anastomoses in Patients With Colitis-associated Neoplasia NK Cleveland, JE Ollech, RJ Colman, D Rodriquez, A Hirsch, RD Cohen, ... Clinical gastroenterology and hepatology: the official clinical practice …, 2019 | 12 | 2019 |
| Outcomes of colitis-associated dysplasia after referral from the community to a tertiary center DT Rubin, NK Cleveland, DM Rodriquez Gastrointestinal Endoscopy 84 (6), 1078-1079, 2016 | 12 | 2016 |
| Ozanimod in the treatment of ulcerative colitis: initial real-world data from a large tertiary center NA Cohen, D Choi, T Choden, NK Cleveland, RD Cohen, DT Rubin Clinical Gastroenterology and Hepatology 21 (9), 2407-2409. e2, 2023 | 11 | 2023 |
